People frequently use medical cannabis to treat anxiety, depression and PTSD, but two new reviews show there is little ...
SANTA ANA, CA - March 16, 2026 - PRESSADVANTAGE - Moment of Clarity has published a new educational resource detailing ...
Following a successful End-of-Phase 2 (EOP2) meeting with the U.S. Food and Drug Administration (FDA) announced in March 2026, the Phase 3 program for BPL-003 in TRD remains on track for initiation in ...
The Healthy @Reader's Digest on MSN
I took the new postpartum depression pill—here’s what happened
A new mom shares how the recently approved two-week postpartum depression drug was a game-changer to combat a notably common condition during a tender phase of life.
TMS is a well-established therapy for treatment-resistant depression. Large clinical studies show that it significantly reduces symptoms in 60 to 70% of patients, and 25 to 35% achieve remission. Most ...
About one-third of depression patients do not respond to standard antidepressants. A new treatment called PACE uses ...
As part of panel of experts convened by the U.S Food and Drug Administration (FDA), Case Western Reserve University professor Lee Hoffer voted last week to recommend a new nasal spray for ...
13d
Top FDA drug official is trying to hire a friend who's seeking a bold new warning on antidepressants
The Food and Drug Administration’s top drug regulator, Dr. Tracy Beth Hoeg, is working to hire a researcher and friend who ...
People with psoriasis prescribed bimekizumab have no greater risk for major depressive disorder or suicidal ideation than ...
Understanding what depression is – and what it is not – is often the first step toward relief.
Post-orgasmic illness syndrome is a rare condition that causes extreme exhaustion and muscle pain after ejaculation. A newly ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results